| Literature DB >> 35081371 |
Xun Lin1, Stephen J Gaudino1, Kyung Ku Jang2, Tej Bahadur1, Ankita Singh1, Anirban Banerjee1, Michael Beaupre1, Timothy Chu1, Hoi Tong Wong1, Chang-Kyung Kim3, Cody Kempen1, Jordan Axelrad4, Huakang Huang1, Saba Khalid1, Vyom Shah5, Onur Eskiocak5, Olivia B Parks6, Artan Berisha1, Jeremy P McAleer7, Misty Good8, Miko Hoshino9, Richard Blumberg10, Agnieszka B Bialkowska3, Sarah L Gaffen11, Jay K Kolls12, Vincent W Yang3, Semir Beyaz5, Ken Cadwell13, Pawan Kumar14.
Abstract
The Th17 cell-lineage-defining cytokine IL-17A contributes to host defense and inflammatory disease by coordinating multicellular immune responses. The IL-17 receptor (IL-17RA) is expressed by diverse intestinal cell types, and therapies targeting IL-17A induce adverse intestinal events, suggesting additional tissue-specific functions. Here, we used multiple conditional deletion models to identify a role for IL-17A in secretory epithelial cell differentiation in the gut. Paneth, tuft, goblet, and enteroendocrine cell numbers were dependent on IL-17A-mediated induction of the transcription factor ATOH1 in Lgr5+ intestinal epithelial stem cells. Although dispensable at steady state, IL-17RA signaling in ATOH1+ cells was required to regenerate secretory cells following injury. Finally, IL-17A stimulation of human-derived intestinal organoids that were locked into a cystic immature state induced ATOH1 expression and rescued secretory cell differentiation. Our data suggest that the cross talk between immune cells and stem cells regulates secretory cell lineage commitment and the integrity of the mucosa.Entities:
Keywords: ATOH1; IL-17A; Lgr5; Th17; intestine; organoids; progenitor cells; secretory cell lineage; stem cell
Mesh:
Substances:
Year: 2022 PMID: 35081371 PMCID: PMC8895883 DOI: 10.1016/j.immuni.2021.12.016
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 43.474